What do the main guidelines say?
Two U.S. sources set the starting ages most men hear about, and they line up more than they differ. Both treat PSA screening as a choice you make after understanding the trade-offs, not an automatic test.
| Group | U.S. Preventive Services Task Force (2018) | American Cancer Society |
|---|---|---|
| Average risk | Individual decision from 55 to 69 | Discuss starting at 50, if you expect to live at least 10 more years |
| Black men | Same decision, with risk factored in | Discuss starting at 45 |
| Father or brother diagnosed before 65 | Same decision, with risk factored in | Discuss starting at 45 |
| More than one close relative diagnosed early | Same decision, with risk factored in | Discuss starting at 40 |
| Age 70 and older | Recommends against routine screening | Not offered if life expectancy is under 10 years |
The USPSTF statement dates from 2018, and the Task Force lists an update in progress. The American Cancer Society recommendations were last revised in November 2023.
What does shared decision-making mean from 55 to 69?
It means the test is offered after a real conversation about benefits and harms, and you decide. The USPSTF estimates that PSA screening programs in men 55 to 69 may prevent about 1.3 deaths from prostate cancer per 1,000 men screened over roughly 13 years. That benefit is real but small for any one man.
The harms are just as concrete. False-positive results lead to more testing and sometimes a biopsy, and some cancers found would never have caused trouble, yet their treatment can bring incontinence or erectile dysfunction. The Task Force also says clinicians should not screen men who do not want it. A good conversation covers your family history, your health and how you weigh those outcomes.
Who should start earlier, and how much earlier?
Men at higher risk are advised to start the conversation at 40 or 45. The National Cancer Institute notes that some organizations recommend routine PSA testing beginning at 40 or 45 for men at higher risk, naming Black men, men with inherited BRCA2 variants (and to a lesser extent BRCA1), and men whose father or brother had prostate cancer.
The reasons are concrete. The USPSTF reports that Black men in the United States develop prostate cancer at a higher rate than white men and are more than twice as likely to die of it, partly because it tends to appear earlier and more aggressively. Family history and inherited gene variants raise risk in a similar way. Our page on family history of prostate cancer explains what counts as a strong history, and our BRCA testing for men page covers the genetic side.
How often should you repeat the test?
That depends on your result. The American Cancer Society suggests that men with a PSA below 2.5 ng/mL may only need a retest every 2 years, while men at 2.5 ng/mL or higher should be screened yearly.
A single high number is not the end of the road. Ejaculation, long rides, infections and recent procedures can all raise PSA for a while, which is why our page on what can raise PSA temporarily is worth reading before you react to a result. In the borderline range, a free PSA test can help sort benign enlargement from a reason to look closer.
When does screening usually stop?
For most men, around 70. The USPSTF recommends against routine PSA screening from age 70 because the potential benefits do not outweigh the harms at that age, including more false positives and complications from biopsy and treatment. The American Cancer Society frames it by health rather than age alone: men without symptoms who are not expected to live another 10 years are unlikely to benefit.
Some healthy men over 70 still ask for testing, and the USPSTF acknowledges that. If you are in that group, ask about the specific trade-offs for someone your age and health.
Does PSA screening change before testosterone therapy?
Yes. Starting testosterone turns PSA from an optional screen into a monitoring test. The Endocrine Society guideline suggests a shared decision about prostate monitoring for men 55 to 69 considering treatment, and for men 40 to 69 at increased risk, such as Black men and men with a first-degree relative with prostate cancer.
The same guideline advises against testosterone therapy without further urological evaluation when PSA is above 4 ng/mL, or above 3 ng/mL in a man at high risk. Our page on a high PSA before TRT covers what happens in that case.
How Ultimate Male fits PSA into your plan
PSA is part of the TRT pre-screening panel, so every man evaluated for testosterone therapy at our San Gabriel and Downey clinics has a baseline. For men who want screening for its own sake, the visit is a chance to go through your age, family history and preferences with a PA-C or MD before deciding.
Men with a strong family history can ask about the Cancer Risk Insight Panel, which offers optional BRCA screening. A raised PSA is checked for temporary causes first, and one that persists needs a urology evaluation. You can compare all of our preventative blood testing options or start with the free 10-minute call.
